Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taiwan Not To Have Adimmune Vaccine ‘Until November At Earliest'

This article was originally published in PharmAsia News

Executive Summary

Adimmune, Taiwan's only producer of an H1N1 flu vaccine, says it does not expect to begin human trials on its drug until October. Tests are underway on animals for a two-dose variety of the vaccine. The minister of health said the vaccine would not be available to the public "until November at the earliest." The government already has ordered all of the 5 million doses Adimmune expects to produce, so it is looking abroad for other suppliers, particularly ones that might be able to deliver ahead of Adimmune. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072630

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel